Cargando…
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
Skin toxicity, a common drug-related adverse event observed in cancer patients treated with epidermal growth factor receptor (EGFR)-directed therapies is rarely seen with therapies targeting HER2. This study reports the significance of the EGFR and HER2 dimerization status in skin with regard to the...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361091/ https://www.ncbi.nlm.nih.gov/pubmed/16306877 http://dx.doi.org/10.1038/sj.bjc.6602875 |